Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|April 24, 2017
Maternal immunisation: collaborating with mother natureArnaud Marchant, Manish Sadarangani, Mathieu Garand, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 24, 2021
Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019Lorenzo Subissi, Nathalie Bossuyt, Marijke Reynders, et al.
The Lancet. Microbe|May 3, 2021
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance studyNatalie Fischer, Nicolas Dauby, Nathalie Bossuyt, et al.
JCI Insight|April 5, 2022
Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19Elisa Brauns, Abdulkader Azouz, David Grimaldi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2025
Rapid increase in serotype 4 invasive pneumococcal disease among vulnerable young male adults in Belgium (2020-2024)Lize Cuypers, Gerardo J Sanchez, Juan Paulo Herrera Avila, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 20, 2023
Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020Natalie Fischer, Sarah Moreels, Nicolas Dauby, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 24, 2020
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose OptimizationPauline Thémans, Leila Belkhir, Nicolas Dauby, et al.
Frontiers in Public Health|July 10, 2023
Public health impact and return on investment of Belgium's pediatric immunization programJustin Carrico, Claire E Mellott, Sandra E Talbird, et al.
Frontiers in Immunology|August 29, 2022
Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortalityPhilomène Lavis, Sofia Morra, Carmen Orte Cano, et al.
Pageof 11